On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease.
D000293:Adolescent; D000328:Adult; D000936:Antigen-Antibody Complex; D001803:Blood Transfusion; D002648:Child; D005169:Factor VIII / Q000008:administration & dosage / Q000032:analysis / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D012310:Ristocetin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D014842:von Willebrand Diseases / Q000097:blood* / Q000188:drug therapy
D000936:Antigen-Antibody Complex; D007074:Immunoglobulin G; D012310:Ristocetin; D005169:Factor VIII